Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis

Abstract

rhIFNalpha-2a is effective in ocular Behçet's disease, leading to significant improvement of vision and complete remission of ocular vasculitis in the majority of the patients.